PHARMACOKINETIC INTERACTION BETWEEN INTRAVENOUS PHENYTOIN AND AMIODARONE IN HEALTHY-VOLUNTEERS

被引：36

作者：

NOLAN, PE

MARCUS, FI

HOYER, GL

BLISS, M

GEAR, K

机构：

[1] UNIV ARIZONA,COLL PHARM,DEPT PHARMACEUT SCI,TUCSON,AZ 85721

[2] UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,DIV CARDIOL,TUCSON,AZ 85721

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 46卷 / 01期

关键词：

D O I：

10.1038/clpt.1989.104

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：43 / 50

页数：8

相关论文

共 30 条

[1] MECHANISM OF WARFARIN POTENTIATION BY AMIODARONE - DOSE-DEPENDENT AND CONCENTRATION-DEPENDENT INHIBITION OF WARFARIN ELIMINATION
ALMOG, S
SHAFRAN, N
HALKIN, H
WEISS, P
FARFEL, Z
MARTINOWITZ, U
BANK, H
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) : 257 - 261
[2] MEAN RESIDENCE TIME CONCEPTS FOR PHARMACOKINETIC SYSTEMS WITH NONLINEAR DRUG ELIMINATION DESCRIBED BY THE MICHAELIS-MENTEN EQUATION
CHENG, HY
JUSKO, WJ
[J]. PHARMACEUTICAL RESEARCH, 1988, 5 (03) : 156 - 164
[3] PHARMACOKINETIC EVALUATION OF THE DIGOXIN-AMIODARONE INTERACTION
FENSTER, PE
WHITE, NW
HANSON, CD
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (01) : 108 - 112
[4] GANNAWAY WL, 1983, CLIN PHARMACY, V2, P135
[5] GIBALDI M, 1982, PHARMACOKINETICS, P63
[6] INTERACTION OF AMIODARONE AND DIPHENYLHYDANTOIN
GORE, JM
HAFFAJEE, CI
ALPERT, JS
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (08) : 1145 - 1145
[7] GRECHBELANGER O, 1984, RES COMMUN CHEM PATH, V44, P15
[8] THE EFFECT OF AMIODARONE ON THEOPHYLLINE PHARMACOKINETICS IN THE RAT
LARIJANI, GE
ROCCI, ML
MOJAVERIAN, P
SACCAR, CL
HOHOLICK, C
VLASSES, PH
[J]. PHARMACEUTICAL RESEARCH, 1986, 3 (03) : 167 - 169
[9] MARCUS FI, 1988, CONTROL CARDIAC ARRH, P543
[10] MASON JW, 1987, NEW ENGL J MED, V316, P455